EIPICO to raise capital to EGP1.68B via cash subscription

Updated 10/24/2024 10:09:00 AM
EIPICO to raise capital to EGP1.68B via cash subscription

Arab Finance: The Egyptian International Pharmaceutical Industries Company (EIPICO) has announced plans to increase its authorized capital from EGP 1.5 billion to EGP 6 billion.

The decision, disclosed in a statement to the Egyptian Exchange (EGX), outlines a capital increase from EGP 1.48 billion to EGP 1.68 billion.

The EGP 200 million increase will be distributed across 20 million shares.

The pricing is based on a fair value study conducted by Eagle Company, an independent financial advisor.

Notably, the capital increase will incur no-issuance expenses.

The move will take place through a cash subscription, available to existing shareholders, with subscription rights being traded separately from the original shares.

Related News

EGX closes Tuesday’s session in red zone Updated 7/1/2025 3:00:00 PM
EGX shows mixed performance on Monday Updated 6/30/2025 3:18:00 PM
EGX sees bullish trend on Sunday Updated 6/29/2025 3:17:00 PM
EGX shows positive performance on Wednesday Updated 6/25/2025 2:59:00 PM
FRA approves Dice’s capital hike Updated 6/24/2025 11:18:00 AM